Preview

Herbarium

Advanced search

Medicinal plants in the treatment and prevention of respiratory diseases (review)

https://doi.org/10.33380/3034-3925-2025-2-1-18

Abstract

Introduction. The aim of the review is to summaries information on medicinal plants used in the prevention of respiratory diseases.

Text. According to Rosstat data, respiratory diseases occupy leading positions in the Russian Federation from year to year. For the treatment of acute respiratory diseases plant medicines are used, including Glycyrrhiza glabra L., Mentha spicata L., Eucalyptus globulus Labill., Citrus sinensis (L.) Pers., Cinnamomum camphora J. Presl.

Conclusion. The given extracts of medicinal plants have a long experience of application in traditional and scientific medicine, contain a complex of biologically active substances such as essential oils, saponins, polyphenols and polysaccharides with antibacterial, anti-inflammatory, analgesic and other effects that will allow in the complex therapy of acute tonsillopharyngitis, relieve the symptoms of the disease.

About the Authors

Natalia V. Bobkova
I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University); Lomonosov Moscow State University
Russian Federation

8/2, Trubetskaya str., Mosсow, 119991

27/1, Lomonosovsky prospect, Moscow, 119192



Larissa A. Kulikova
Sun Pharmaceutical Industries Ltd. (Sun Pharma)
Russian Federation

27/8, Elektrozavodskaya str., Moscow, 107023



References

1. Roggen I., van Berlaer G., Gordts F., Pierard D., Hubloue I. Acute sore throat in children at the emergency department: best medical practice? European Journal of Emergency Medicine. 2015;22(5):343–347. DOI: 10.1097/MEJ.0000000000000175.

2. Windfuhr J. P., Toepfner N., Steffen G., Waldfahrer F., Berner R. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. European Archives of Oto-Rhino-Laryngology. 2016;273:973–987. DOI: 10.1007/s00405-015-3872-6.

3. Moriyama M., Hugentobler W. J., Iwasaki A. Seasonality of respiratory viral infections. Annual Review of Virology. 2020;7:83– 101. DOI: 10.1146/annurev-virology-012420-022445.

4. Fendrick A. M., Monto A. S., Nightengale B., Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Archives of Internal Medicine. 2003;163(4):487–494. DOI: 10.1001/archinte.163.4.487.

5. Molinari N.-A. M., Ortega-Sanchez I. R., Messonnier M. L., Thompson W. W., Wortley P. M., Weintraub E., Bridges C. B. The annual impact of seasonal influenza in the US: Measuring disease burden and costs. Vaccine. 2007;25(27):5086– 5096. DOI: 10.1016/j.vaccine.2007.03.046.

6. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K. S. M., Lau E. H. Y., Wong J. Y., Xing X., Xiang N., Wu Y., Li C., Chen Q., Li D., Liu T., Zhao J., Liu M., Tu W., Chen C., Jin L., Yang R., Wang Q., Zhou S., Wang R., Liu H., Luo Y., Liu Y., Shao G., Li H., Tao Z., Yang Y., Deng Z., Liu B., Ma Z., Zhang Y., Shi G., Lam T. T. Y., Wu J. T., Gao G. F., Cowling B. J., Yang B., Leung G. M., Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus– infected pneumonia. New England Journal of Medicine. 2020;382(13):1199–1207. DOI: 10.1056/NEJMoa2001316.

7. Osikov M. V., Davydova E. V., Kovalev M. A. Features of the state of mucosal-associated laryngeal tissue in chronic edematous polyposis laryngitis. Sovremennye problemy nauki i obrazovaniya. 2020;3:138–138. (In Russ.)

8. Stepanova Yu. E., Konoplev O. I., Gotovyakhina T. V., Koren’ E. E., Mal’tseva G. S. Acute and chronic laryngitis in the subjects engaged in the voice and speech professions. Vestnik otorinolaringologii. 2019;84(1):68–71. (In Russ.) DOI: 10.17116/otorino20198401168.

9. Stachler R. J., Francis D. O., Schwartz S. R., Damask C. C., Digoy G. P., Krouse H. J., McCoy S. J., Ouellette D. R., Patel R. R., Reavis C. W., Smith L. J., Smith M., Strode S. W., Woo P., Nnacheta L. C. Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngology–Head and Neck Surgery. 2018;158(1):S1–S42. DOI: 10.1177/0194599817751030.

10. Niederman M. S., Torres A. Respiratory infections. European Respiratory Review. 2022;31(166):220150. DOI: 10.1183/16000617.0150-2022.

11. Kumar K., Daley C. L., Griffith D. E., Loebinger M. R. Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments. European Respiratory Review. 2022:31(163): 210212. DOI: 10.1183/16000617.0212-2021.

12. Luchsheva Yu. V. Sore throat and methods for its correction with local drugs. Russian Medical Inquiry. 2011;19(24):1468– 1470. (In Russ.)

13. Radtsig E. Yu., Sel’kova E. P., Zlobina N. V. The role of respiratory viruses in nasopharynx microbiome in children. Rossiiskaya otorinolaringologiya. 2017;3:72–77. (In Russ.) DOI: 10.18692/1810-4800-2017-3-72-77.

14. Maltseva G. S. Treatment of patients with acute tonsillopharyngitis. Spravochnik poliklinicheckogo vracha. 2012;(7):23–27. (In Russ.)

15. Ovcharenko S. I. Cough: etiology, diagnosis, approaches to treatment. Consilium medicum. 2006;8(1):22–26. (In Russ.)

16. Spinks A., Glasziou P. P., Del Mar C. B. Antibiotics for treatment of sore throat in children and adults. Cochrane Database of Systematic Reviews. 2021;12. DOI: 10.1002/14651858.CD000023.pub5.

17. Krüger K., Töpfner N., Berner R., Windfuhr J., Oltrogge J. H. Sore throat. Deutsches Ärzteblatt International. 2021;118(11):188–194. DOI: 10.3238/arztebl.m2021.0121.

18. Thillaivanam S., Amin A. M., Gopalakrishnan S., Ibrahim B. The effectiveness of the McIsaac clinical decision rule in the management of sore throat: an evaluation from a pediatric ward. Pediatric Research. 2016;80(4):516–520. DOI: 10.1038/pr.2016.113.

19. Shulman S. T., Bisno A. L., Clegg H. W., Gerber M. A., Kaplan E. L., Lee G., Martin J. M., Van Beneden C. IDSA Clinical Guideline for Diagnosis and Treatment of pharyngitis caused by group A streptococci: 2012 update. Vestnik prakticheskogo vracha. 2013;1:12–28. (In Russ.)

20. Sharland M., Kendall H., Yeates D., Randall A., Hughes G., Glasziou P., Mant D. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: time trend analysis. BMJ. 2005;331:328. DOI: 10.1136/BMJ.38503.706887.AE1.

21. Zwart S., Rovers M. M., de Melker R. A., Hoes A. W. Penicillin for acute sore throat in children: randomised, double blind trial. Commentary: More valid criteria may be needed. BMJ. 2003;327:1324. DOI: 10.1136/bmj.327.7427.1324.

22. Gill J. M., Fleischut P., Haas S., Pellini B., Crawford A., Nash D. B. Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study. Family Medicine. 2006;38(5):349–354.

23. Wenzel R. P., Edmond M. B. Managing antibiotic resistance. New England Journal of Medicine. 2000;343(26):1961–1963. DOI: 10.1056/NEJM200012283432610.

24. Falagas M. E., Giannopoulou K. P., Vardakas K. Z., Dimopoulos G., Karageorgopoulos D. E. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. The Lancet Infectious Diseases. 2008;8(9):543–552. DOI: 10.1016/S1473-3099(08)70202-0.

25. Radtsig E. Yu., Gurov A. V. Sore throat. Crossing problems and finding solutions. Russian Journal of Woman and Child Health. 2022;5(3):228–236. (in Russ.) DOI: 10.32364/2618-8430-2022-5-3-228-236.

26. Savlevich E.L., Doroschenko N.E., Slavinskaya I.S., Farikov S.E. Important factors of the inflammatory process in the o ropharynx and optimal treatment regimes selection. Medical Council. 2017;(16):48–54. (In Russ.) DOI: 10.21518/2079-701X-2017-16-48-54.

27. Ovchinnikov A. Yu., Miroshnichenko N. A., Ekaterinchev V. A., Smirnov I. V. Upper respiratory tract infections in children and adults: otorhinolaryngologist’s recommendations. RMJ. 2016;26:1739–1742. (In Russ.)

28. Thomas M., Del Mar C., Glasziou P. How effective are treatments other than antibiotics for acute sore throat? British Journal of General Practice. 2000;50(459):817–820.

29. Dyadyk A., Kugler T., Tsyba I., Gnilitskaya V., Kaluga A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: mechanisms, clinical presentations, prevention. Vrach. 2017;(11):7–12. (In Russ.)

30. Shabrova A. V., Uspensky Yu. P. Lesions of the digestive organs induced by taking non-steroidal anti-inflammatory drugs. St. Petersburg: InformMed; 2013. 284 p. (In Russ.)

31. Sohail R., Mathew M., Patel K. K., Reddy S. A., Haider Z., Naria M., Habib A., Abdin Z. U., Chaudhry W. R., Akbar A. Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review. Cureus. 2023;15(4). DOI: 10.7759/cureus.37080.

32. Alhammadi N., Asiri A. H., Alshahrani F. M., Alqahtani A. Y., Al Qout M. M., Alnami R. A., Alasiri A. S., AL-Zomia A. S. Gastrointestinal complications associated with non-steroidal anti-inflammatory drug use among adults: a retrospective, single-center study. Cureus. 2022;14(6). DOI: 10.7759/cureus.26154.

33. Smruti P. A review on natural remedies used for the treatment of respiratory disorders. International Journal of Pharmaceutics. 2021;8(3):104–111. DOI: 10.13040/IJPSR.0975-8232.IJP.8(3).104-11.

34. Orlova N. V. The place of phytotherapy in the treatment of acute upper respiratory tract infections. Medical Council. 2022;(20):65–71. (In Russ.) DOI: 10.21518/2079-701X-2022-16-20-65-71.

35. Lesiovskaya E. E., Pastushenkov L. V. Pharmacotherapy with the basics of herbal medicine. 2nd ed. Moscow: Geotar Medicine; 2003. 592 p. (In Russ.)

36. Kurkin V. A. Fundamentals of herbal medicine. Samara: LLC "Ofort"; 2009. 963 p. (In Russ.)

37. Büttner R., Schwermer M., Ostermann T., Längler A., Zuzak T. Complementary and alternative medicine in the (symptomatic) treatment of acute tonsillitis in children: A systematic review. Complementary Therapies in Medicine. 2023;73:102940. DOI: 10.1016/j.ctim.2023.102940.

38. Stremoukhov A. A., Zaplatnikov A. L., Vlasova N. L., Smirnova M. A. Phytotherapy of infectious & inflammatory upper airway diseases in outpatient care and general practitioner settings. Russian Medical Inquiry. 2022;6(8):419–426. (In Russ.) DOI: 10.32364/2587-6821-2022-6-8-419-426.

39. Svistushkin V. M, Morozova S. V., Keda L. A. Topical aspects of the use of phytopreparations in acute infectious and inflammatory diseases of the upper respiratory tract. Medical Council. 2021;(6):36–42. (In Russ.) DOI: 10.21518/2079-701X-2021-6-36-42.

40. Petrushkina N. P., Zhukovskaya E. V. A brief outline of the history of herbal medicine. Pediatric Bulletin of the South Ural. 2018;(1):64–70. (In Russ.)

41. Reichling J., Schnitzler P., Suschke U., Saller R. Essential Oils of Aromatic Plants with Antibacterial, Antifungal, Antiviral, and Cytotoxic Properties – an Overview. Complementary Medicine Research. 2009;16(2):79–90. DOI: 10.1159/000207196.

42. Silva-Beltrán N. P., Boon S. A., Ijaz M. K., McKinney J., Gerba C. P. Antifungal activity and mechanism of action of natural product derivates as potential environmental disinfectants. Journal of Industrial Microbiology and Biotechnology. 2023;50(1):kuad036. DOI: 10.1093/jimb/kuad036.

43. Boone S. A., Ijaz M. K., Bright K. R., Silva-Beltran N. P., Nims R. W., McKinney J., Gerba C. P. Antiviral Natural Products, Their Mechanisms of Action and Potential Applications as Sanitizers and Disinfectants. Food and Environmental Virology. 2023;15(4):265–280. DOI: 10.1007/s12560-023-09568-x.

44. Mamedov N. A., Egamberdieva D. Phytochemical constituents and pharmacological effects of licorice: a review. In: Plant and Human Health. Volume 3. Pharmacology and therapeutic uses. Luxembourg: Springer; 2019. P. 1–21. DOI: 10.1007/978-3-030-04408-4_1.

45. WHO monographs. about medicinal plants widely used in the Newly Independent States (NIS). Moscow: World Health Organization; 2010. 464 p. (In Russ.)

46. Kaur R., Kaur H., Dhindsa A. S. Glycyrrhiza glabra: a phytopharmacological review. International Journal of Pharmaceutical Sciences and Research. 2013;4(7):2470. DOI: 10.13040/IJPSR.0975-8232.4(7).2470-77.

47. Bisht D., Rashid M., Kant Arya R. K., Kumar D., Chaudhary S. K., Rana V. S., Sethiya N. K. Revisiting liquorice (Glycyrrhiza glabra L.) as anti-inflammatory, antivirals and immunomodulators: Potential pharmacological applications with mechanistic insight. Phytomedicine Plus. 2022;2(1):100206. DOI: 10.1016/j.phyplu.2021.100206.

48. He L., Kang Q., Zhang Y., Chen M., Wang Z., Wu Y., Tan W., Gao H., Zhong Z., Tan W. Glycyrrhizae Radix et Rhizoma: The popular occurrence of herbal medicine applied in classical prescriptions. Phytotherapy Research. 2023;37(7):3135– 3160. DOI: 10.1002/ptr.7869.

49. Babich O. O., Ulrikh E. V., Larina V. V., Bakhtiyarova A. K. Study of the composition and properties of extracts of Glycyrrhiza glabra grown in the Kaliningrad region and prospects of its use. Food systems. 2022;5(3):261–270. (In Russ.) DOI: 10.21323/2618-9771-2022-5-3-261-270.

50. Banerjee S., Baidya S. K., Adhikari N., Ghosh B., Jha T. Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences. Journal of Molecular Structure. 2023;1275:134642. DOI: 10.1016/j.molstruc.2022.134642.

51. Ermakova V. A., Samylina I. A., Kovaleva T. Yu., Brovchenko B. V., Dorovskikh E. A., Bobkova N. V. Licorice (Glycyrrhiza) roots: analysis of the requirements of the pharmacopoeia. Pharmacy. 2019;68(6):16–19. (In Russ.) DOI: 10/29296/25419218-2019-06-03.

52. Ghaemi H., Masoompour S. M., Afsharypuor S., Mosaffa-Jahromi M., Pasalar M., Ahmadi F., Niknahad H. The effectiveness of a traditional Persian medicine preparation in the treatment of chronic cough: A randomized, double-blinded, placebo-controlled clinical trial. Complementary Therapies in Medicine. 2020;49:102324. DOI: 10.1016/j.ctim.2020.102324

53. Teixeira M. L., das G. Cardoso M., Figueiredo A. C. S., Moraes J. C., Assis F. A., de Andrade J., Nelson D. L., de Souza Gomes M., de Souza J. A., de Albuquerque L. R. M. Essential oils from Lippia origanoides Kunth. and Mentha spicata L.: Chemical composition, insecticidal and antioxidant activities. American Journal of Plant Sciences. 2014;5(9):1181–1190. DOI: 10.4236/ajps.2014.59131.

54. Snoussi M., Noumi E., Trabelsi N., Flamini G., Papetti A., De Feo V. Mentha spicata essential oil: chemical composition, antioxidant and antibacterial activities against planktonic and biofilm cultures of Vibrio spp. strains. Molecules. 2015;20(8):14402–14424. DOI: 10.3390/molecules200814402.

55. Younis Y. M. H., Beshir S. M. Carvone-rich essential oils from Mentha longifolia (L.) Huds. ssp. schimperi Briq. and Mentha spicata L. grown in Sudan. Journal of Essential Oil Research. 2004;16(6):539–541. DOI: 10.1080/10412905.2004.9698792.

56. Shahbazi Y., Shavisi N. Interactions of Ziziphora clinopodioides and Mentha spicata essential oils with chitosan and ciprofloxacin against common food-related pathogens. LWT - Food Science and Technology. 2016;71:364– 369. DOI: 10.1016/j.lwt.2016.04.011.

57. Bochkarev N. I., Zelentsov S. V., Shuvaeva T. P., Borodkina A. P. Taxonomy, morphology and breeding of menthol mints (review). 2015;2(162):106–124. Maslichnye kultury. (In Russ.)

58. de Paula Pinheiro Menezes Marques S., Oliveira Pinheiro R., do Nascimento R. A., de Aguiar Andrade E. H., Guerreiro de Faria L. J. Effects of Harvest Time and Hydrodistillation Time on Yield, Composition, and Antioxidant Activity of Mint Essential Oil. Molecules. 2023;28(22):7583. DOI: 10.3390/molecules28227583.

59. Mahendran G., Verma S. K., Rahman L.-U. The traditional uses, phytochemistry and pharmacology of spearmint (Mentha spicata L.): A review. Journal of Ethnopharmacology. 2021;278:114266. DOI: 10.1016/j.jep.2021.114266.

60. Bahadori M. B., Zengin G., Bahadori S., Dinparast L., Movahhedin N. Phenolic composition and functional properties of wild mint (Mentha longifolia var. calliantha (Stapf) Briq.). International Journal of Food Properties. 2018;21(1):183–193. DOI: 10.1080/10942912.2018.1440238.

61. Fatiha B., Didier H., Naima G., Khodir M., Martin K., Léocadie K., Caroline S., Mohamed C., Pierre D. Phenolic composition, in vitro antioxidant effects and tyrosinase inhibitory activity of three Algerian Mentha species: M. spicata (L.), M. pulegium (L.) and M. rotundifolia (L.) Huds (Lamiaceae). Industrial Crops and Products. 2015;74:722–730. DOI: 10.1016/j.indcrop.2015.04.038.

62. Kaddour A., Amara D. G., Moussaoui Y., Chemsa A. E., Alia Z., Kamarchou A. Total phenolic and flavonoid contents of Mentha spicata leaves aqueous extracts in different regions of Algeria and their antioxidant, and antidiabetic activities. Tropical Journal of Pharmaceutical Research. 2022;21(9):1907–1913. DOI: 10.4314/tjpr.v21i9.14.

63. Zheng J., Chen G.-T., Gao H.-Y., Wu B., Wu L.-J. Two new lignans from Mentha spicata L. Journal of Asian Natural Products Research. 2007;9(5):431–435. DOI: 10.1080/10286020500384641.

64. Abdul Qadir M., Shahzadi S. K., Bashir A., Munir A., Shahzad S. Evaluation of phenolic compounds and antioxidant and antimicrobial activities of some common herbs. International Journal of Analytical Chemistry. 2017;(1):3475738. DOI: 10.1155/2017/3475738.

65. Park Y. J., Baskar T. B., Yeo S. K., Arasu M. V., Al-Dhabi N. A., Lim S. S., Park S. U. Composition of volatile compounds and in vitro antimicrobial activity of nine Mentha spp. SpringerPlus. 2016;5:1628. DOI: 10.1186/s40064-016-3283-1.

66. Scherer R., Lemos M. F., Lemos M. F., Martinelli G. C., Damasceno Lopes Martins J., Gomes da Silva A. Antioxidant and antibacterial activities and composition of Brazilian spearmint (Mentha spicata L.). Industrial Crops and Products. 2013;50:408–413. DOI: 10.1016/j.indcrop.2013.07.007.

67. Alaklabi A., Arif I. A., Ahamed A., Manilal A., Surendrakumar R., Idhayadhulla A. Larvicidal nematicidal, antifeedant and antifungal, antioxidant activities of Mentha spicata (Lamiaceae) root extracts. Tropical Journal of Pharmaceutical Research. 2016;15(11):2383–2390. DOI: 10.4314/tjpr.v15i11.12.

68. Soković M. D., Vukojević J., Marin P. D., Brkić D. D., Vajs V., Van Griensven L. J. L. D. Chemical composition of essential oils of Thymus and Mentha species and their antifungal activities. Molecules. 2009;14(1):238–249. DOI: 10.3390/molecules14010238.

69. Bayan Y., Küsek M. Chemical composition and antifungal and antibacterial activity of Mentha spicata L. volatile oil. Ciencia e investigación agraria. 2018;45(1):64–69.

70. Chauhan S. S., Prakash O., Padalia R. C., Pant A. K., Mathela C. S. Chemical diversity in Mentha spicata: antioxidant and potato sprout inhibition activity of its essential oils. Natural Product Communications. 2011;6(9):1934578X1100600938. DOI: 10.1177/1934578X1100600938.

71. Choudhury R. P., Kumar A., Garg A. N. Analysis of Indian mint (Mentha spicata) for essential, trace and toxic elements and its antioxidant behaviour. Journal of Pharmaceutical and Biomedical Analysis. 2006;41(3):825–832. DOI: 10.1016/j.jpba.2006.01.048

72. Bayani M., Ahmadi-Hamedani M., Javan A. J. Study of hypoglycemic, hypocholesterolemic and antioxidant activities of Iranian Mentha spicata leaves aqueous extract in diabetic rats. Iranian Journal of Pharmaceutical Research. 2017;16:75–82.

73. Joshi A., Sharma A., Bachheti R. K., Pandey D. P. A comparative study of the chemical composition of the essential oil from Eucalyptus globulus growing in Dehradun (India) and around the world. Oriental Journal of Chemistry. 2016;32(1):331–340. DOI: 10.13005/ojc/320137.

74. Boulekbache‐Makhlouf L., Meudec E., Mazauric J.-P., Madani K., Cheynier V. Qualitative and semi‐quantitative analysis of phenolics in Eucalyptus globulus leaves by highperformance liquid chromatography coupled with diode array detection and electrospray ionisation mass spectrometry. Phytochemical Analysis. 2013;24(2):162–170. DOI: 10.1002/pca.2396.

75. Santos S. A. O., Freire C. S. R., Domingues M. R. M., Silvestre A. J. D., Neto C. P. Characterization of phenolic components in polar extracts of Eucalyptus globulus Labill. bark by high-performance liquid chromatographymass spectrometry. Journal of Agricultural and Food Chemistry. 2011;59(17):9386–9393. DOI: 10.1021/jf201801q.

76. Zhang J., An M., Wu H., Stanton R., Lemerle D. Chemistry and bioactivity of Eucalyptus essential oils. Allelopathy Journal. 2010;25(2):313–330.

77. Tampieri M. P., Galuppi R., Macchioni F., Carelle M. S., Falcioni L., Cioni P. L., Morelli I. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia. 2005;159:339–345. DOI: 10.1007/s11046-003-4790-5.

78. Damjanović-Vratnica B., Đakov T., Šuković D., Damjanović J. Antimicrobial effect of essential oil isolated from Eucalyptus globulus Labill. from Montenegro. Czech Journal of Food Sciences. 2011;29(3):277–284. DOI: 10.17221/114/2009-CJFS.

79. Chebli B., Hmamouchi M., Achouri M., Idrissi Hassani L. M. Composition and in vitro fungitoxic activity of 19 essential oils against two post-harvest pathogens. Journal of Essential Oil Research. 2004;16(5):507–511. DOI: 10.1080/10412905.2004.9698783.

80. Khaddor M., Lamarti A., Tantaoui-Elaraki A., Ezziyyani M., Candela Castillo M.-E., Badoc A. Antifungal activity of three essential oils on growth and toxigenesis of Penicillium aurantiogriseum and Penicillium viridicatum. Journal of Essential Oil Research. 2006;18(5):586–589. DOI: 10.1080/10412905.2006.9699175.

81. Aazza S., Lyoussi B., Megias C., Cortes-Giraldo I., Vioque J., Figueiredo A. C., Miguel M. G. Anti-oxidant, anti-inflammatory and anti-proliferative activities of Moroccan commercial essential oils. Natural Product Communications. 2014;9:587–594. DOI: 10.1177/1934578X1400900442.

82. Cermelli C., Fabio A., Fabio G., Quaglio P. Effect of eucalyptus essential oil on respiratory bacteria and viruses. Current Microbiology. 2008;56(1):89–92. DOI: 10.1007/s00284-007-9045-0.

83. Khedhri S., Polito F., Caputo L., Manna F., Khammassi M., Hamrouni L., Amri I., Nazzaro F., De Feo V., Fratianni F. Chemical Composition, Phytotoxic and Antibiofilm Activity of Seven Eucalyptus Species from Tunisia. Molecules. 2022;27(23):8227. DOI: 10.3390/molecules27238227.

84. Ameur E., Sarra M., Yosra D., Mariem K., Nabil A., Lynen F., Larbi K. M. Correction to: Chemical composition of essential oils of eight Tunisian Eucalyptus species and their antibacterial activity against strains responsible for otitis. BMC Complementary Medicine and Therapies. 2021;21:241. DOI: 10.1186/s12906-021-03412-0.

85. Miyamoto C. T., Rocha de Sant’anna J., da Silva Franco C. C., Cunico M. M., Miguel O. G., Côcco L. C., Yamamoto C. I., Corrêa C., De Castro-Prado M. A. A. Genotoxic activity of Eucalyptus globulus essential oil in Aspergillus nidulans diploid cells. Folia Microbiologica. 2009;54:493–498. DOI: 10.1007/s12223-009-0070-1.

86. WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS). In: WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS). Geneva: World Health Organization; 2010. 441 p.

87. Moreira P., Matos P., Figueirinha A., Salgueiro L., Batista M. T., Costa Branco P., Cruz M. T., Pereira C. F. Forest Biomass as a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences. 2022;23(15):8812. DOI: 10.3390/ijms23158812.

88. Takhtadzhyan A. L., editor. Flowering plants. Volume 5. Part 2. Moscow: Prosveschenie; 1981. 511 p. (In Russ.)

89. Favela-Hernández J. M. J., González-Santiago O., Ramírez-Cabrera M. A., Esquivel-Ferriño P. C., Del Rayo Camacho-Corona M. Chemistry and pharmacology of Citrus sinensis. Molecules. 2016;21(2):247. DOI: 10.3390/molecules21020247.

90. Kaviya S., Santhanalakshmi J., Viswanathan B., Muthumary J., Srinivasan K. Biosynthesis of silver nanoparticles using Citrus sinensis peel extract and its antibacterial activity. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2011;79(3):594–598. DOI: 10.1016/j.saa.2011.03.040.

91. Naila A., Nadia D., Zahoor Q. S. Stable silver nanoparticles synthesis by Citrus sinensis (orange) and assessing activity against food poisoning microbes. Biomedical and Environmental Sciences. 2014;27(10):815–818. DOI: 10.3967/bes2014.118.

92. Chalova V. I., Crandall P. G., Ricke S. C. Microbial inhibitory and radical scavenging activities of cold-pressed terpeneless Valencia orange (Citrus sinensis) oil in different dispersing agents. Journal of the Science of Food and Agriculture. 2010;90:870–876. DOI: 10.1002/jsfa.3897.

93. Hamdi A., Horchani M., Jannet H. B., Snoussi M., Noumi E., Bouali N., Kadri A., Polito F., De Feo V., Edziri H. In vitro screening of antimicrobial and anti-coagulant activities, ADME profiling, and molecular docking study of Citrus limon L. and Citrus paradisi L. cold-pressed volatile oils. Pharmaceuticals. 2023;16(12):1669. DOI: 10.3390/ph16121669.

94. Trovato A., Monforte M. T., Forestieri A. M., Pizzimenti F. In vitro anti-mycotic activity of some medicinal plants containing flavonoids. Bollettino Chimico Farmaceutico. 2000;139(5):225–227.

95. Singh P., Shukla R., Prakash B., Kumar A., Singh S., Mishra P. K., Dubey N. K. Chemical profile, antifungal, antiaflatoxigenic and antioxidant activity of Citrus maxima Burm. and Citrus sinensis (L.) Osbeck essential oils and their cyclic monoterpene, DL-limonene. Food and Chemical Toxicology. 2010;48(6):1734–1740. DOI: 10.1016/j.fct.2010.04.001.

96. Bagavan A., Rahuman A. A., Kamaraj C., Kaushik N. K., Mohanakrishnan D., Sahal D. Antiplasmodial activity of botanical extracts against Plasmodium falciparum. Parasitology Research. 2011;108(5):1099–1109. DOI: 10.1007/s00436-010-2151-0.

97. Bhat G. P., Surolia N. In vitro antimalarial activity of extracts of three plants used in the traditional medicine of India. American Journal of Tropical Medicine and Hygiene. 2001;65:304–308. DOI: 10.4269/ajtmh.2001.65.304.

98. Habila N., Agbaji A. S., Ladan Z., Bello I. A., Haruna E., Dakare M. A., Atolagbe T. O. Evaluation of In Vitro Activity of Essential Oils against Trypanosoma brucei brucei and Trypanosoma evansi. Journal of Parasitology Research. 2010;2010:534601. DOI: 10.1155/2010/534601.

99. Costa Goes T., Dias Antunes F., Barreto Alves P., Teixeira-Silva F. Effect of sweet orange aroma on experimental anxiety in humans. The Journal of Alternative and Complementary Medicine. 2012;18(8):798–804. DOI: 10.1089/acm.2011.0551.

100. Brito Faturi C., Leite J. R., Barreto Alves P., Conte Canton A., Teixeira-Silva F. Anxiolytic-like effect of sweet orange aroma in Wistar rats. Progress in Neuro-Psychopharmaco-logy and Biological Psychiatry. 2010;34(4):605–609. DOI: 10.1016/j.pnpbp.2010.02.020.

101. Lee S.-H., Kim D.-S., Park S.-H., Park H. Phytochemistry and Applications of Cinnamomum camphora Essential Oils. Molecules. 2022;27(9):2695. DOI: 10.3390/molecules27092695.

102. Bottoni M., Milani F., Mozzo M., Radice Kolloffel D. A., Papini A., Fratini F., Maggi F., Santagostini L. Sub-Tissue Localization of Phytochemicals in Cinnamomum camphora (L.) J. Presl. Growing in Northern Italy. Plants. 2021;10(5):1008. DOI: 10.3390/plants10051008.

103. Wang J., Su B., Jiang H., Cui N., Yu Z., Yang Y., Sun Y. Traditional uses, phytochemistry and pharmacological activities of the genus Cinnamomum (Lauraceae): A review. Fitoterapia. 2020;146:104675. DOI: 10.1016/j.fitote.2020.104675.

104. Lee H. J., Hyun E.-A., Yoon W. J., Kim B. H., Rhee M. H., Kang H. K., Cho J. Y., Yoo E.vS. In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. Journal of Ethnopharmacology. 2006;103(2):208– 216. DOI: 10.1016/j.jep.2005.08.009.

105. Xiao S., Yu H., Xie Y., Guo Y., Fan J., Yao W. The anti-inflammatory potential of Cinnamomum camphora (L.) J. Presl essential oil in vitro and in vivo. Journal of Ethnopharmacology. 2021;267:113516. DOI: 10.1016/j.jep.2020.113516.

106. Kang N.-J., Han S.-C., Yoon S.-H., Sim J.-Y., Maeng Y. H., Kang H.-K., Yoo E.-S. Cinnamomum camphora leaves alleviate allergic skin inflammatory responses in vitro and in vivo. Toxicological Research. 2019;35:279–285. DOI: 10.5487/TR.2019.35.3.279.


Supplementary files

1. Графический абстракт
Subject
Type Исследовательские инструменты
View (1MB)    
Indexing metadata ▾

Review

For citations:


Bobkova N.V., Kulikova L.A. Medicinal plants in the treatment and prevention of respiratory diseases (review). Herbarium. 2025;2(1):40-53. (In Russ.) https://doi.org/10.33380/3034-3925-2025-2-1-18

Views: 195


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-3925 (Online)